Malignant hypertension in brattleboro (vasopressin-deficient) rats

Robyn L. Woods, Josephine M. Abrahams, Priscilla Kincaid-Smith, Colin I. Johnston

    Research output: Contribution to journalArticleResearchpeer-review

    2 Citations (Scopus)


    The role of arginine vasopressin (AVP) in malignant renal hypertension was investigated using the homozygous Brattieboro (vasopressin-deficient) rat. Brattieboro rats with complete aortic-iigature between the renal arteries developed malignant hypertension with the same frequency and severity as normal Long-Evans rats subjected to the same procedure. The Long-Evaris hypertensive rats had significantly elevated plasma AVP levels. Plasma renin activity and plasma angiotensin II levels were significantly elevated in both Brattieboro and Long-Evans rats with malignant hypertension and the levels reached were equivalent in both groups. Thus, the renin-angiotensin system did not compensate for the lack of AVP in malignant hypertensive Brattieboro rats. Specific vascular lesions of fibrinoid necrosis were observed in a high percentage of rats with malignant hypertension, in both the Brattieboro and Long-Evans strains. We conclude that AVP does not play a primary role in the pathogenesis of malignant renal hypertension and, in particular, in the development of the vascular lesions of fibrinoid necrosis.

    Original languageEnglish
    Pages (from-to)37-43
    Number of pages7
    JournalJournal of Hypertension
    Issue number1
    Publication statusPublished - 1983


    • Arginine vasopressin
    • Brattieboro
    • Fibrinoid necrosis
    • Malignant renal hypertension

    Cite this